Lahore: Liven Pharma Limited, a notable entity in the pharmaceuticals sector, convened a pivotal board meeting in Lahore on October 2, 2026, to deliberate on the company’s financials and associated matters. The meeting commenced at 4:00 PM and continues in progress as the board members assess key financial metrics and strategic directives pivotal to the company's operations.

According to the meeting agenda, the board's decisions will be formally communicated on the next working day. Shareholders and stakeholders are advised to anticipate disclosures before market opening times, specifically between 8:00 AM and 9:30 AM from Monday to Thursday, and before 9:15 AM on Fridays, unless otherwise notified by the exchange under special conditions.

In the context of market movements, the Pakistan Stock Exchange (PSX) remains a critical focal point for investors monitoring Liven Pharma’s financial health and strategic directions. According to information available from the Pakistan Stock Exchange (PSX), any developments arising from the board's conclusions are expected to influence market perceptions and investor confidence.

As the board meeting progresses, market participants await the forthcoming announcements, which are anticipated to provide clarity on Liven Pharma Limited's financial standing and future strategies.